BioSpace News Archive

Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today reported financial results and business progress for the first quarter ended March 31, 2021.

Annual Meeting to be adjourned solely with respect to Proposal 3

Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, reported financial and corporate results for the first quarter ended March 31, 2021.

Brooks Automation, Inc. announced that company management will participate in the 16th Annual Needham Virtual Technology & Media Conference on Thursday, May 20, 2021 which includes a webcast beginning at 11:00 a.m. ET.

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, is providing a company update and first quarter 2021 financial results.

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced its management will present at the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 4:00 p.m. Eastern Time.

Announced Plans to Launch Two New Diagnostic Tests - SARS-CoV-2 Neutralization Antibody Detection Test and Next Generation Sequencing Test

Incyte (NASDAQ:INCY) and MorphoSys AG (FSE:MOR; NASDAQ:MOR) today announced that the first patient has been dosed in the pivotal Phase 3 frontMIND study evaluating tafasitamab and lenalidomide in addition to rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) compared to R-CHOP alone as first-line treatment for high-intermediate and high-risk patients with untreated diffuse large B-cell lymphoma

SANUWAVE Health, Inc., a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field announced that it will present at the Q2 Virtual Investor Summit, hosted by the Investor Summit Group, on May 18, 2021.